MLYS Earnings Date: Nov 4, 2026 (Estimated) — Mineralys Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is MLYS's next earnings date?
Mineralys Therapeutics, Inc. (MLYS) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.55.
How did MLYS do in its last earnings report?
In its most recent report on Aug 12, 2026, Mineralys Therapeutics, Inc. posted EPS of -$2.85 versus the -$0.55 estimate, a miss of 419.5%. The stock's 1-day post-earnings move was -4.5%.
How much does MLYS stock move after earnings?
MLYS beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.7% (up or down) in the day after earnings.
About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | -0.55 | -2.85 | -419.50% | — | ❌ Miss | -4.54% | -2.63% | +7.21% | |
| 2026-08-11 | Q2 2026 | -0.54 | -2.85 | -427.78% | $0 | ❌ Miss | -1.02% | -2.63% | +7.21% |
| 2026-05-06 | Q1 2026 | -0.45 | -0.47 | -4.44% | $0 | ❌ Miss | -2.56% | -10.82% | -21.35% |
| 2026-03-12 | Q4 2025 | -0.54 | -0.40 | +25.93% | $0 | ✅ Beat | -2.96% | -13.75% | +0.63% |
| 2025-11-10 | Q3 2025 | -0.63 | -0.52 | +17.46% | $0 | ✅ Beat | +5.87% | -0.54% | -18.65% |
| 2025-08-12 | Q2 2025 | -0.76 | -0.66 | +13.16% | $0 | ✅ Beat | +0.37% | +7.11% | +175.06% |
| 2025-02-12 | Q4 2024 | -1.08 | -0.98 | +9.26% | $0 | ✅ Beat | +10.04% | -3.52% | +39.75% |
| 2024-11-11 | Q3 2024 | -0.83 | -1.13 | -36.14% | $0 | ❌ Miss | -10.32% | -23.59% | -13.20% |
Showing last 8 quarters.